Skip to content

About
R&D
- R&D
- PENAO
Core Businesses
Products
Investors
News
Contact
English
- 简体中文

Search this website

Monthly Archives: January 2021

Home>
2021>
January

Read more about the article Wish You Happy New Year！

Wish You Happy New Year！

Post author:tnt
Post published:2021-01-01
Post category:2021
Post comments:0 Comments

Continue ReadingWish You Happy New Year！

Search Article

Search this website

Arrange by Year

2017 (10)
2018 (24)
2019 (25)
2020 (17)
2021 (11)
2022 (8)
2023 (6)
2024 (8)
2025 (1)

What’s New

Beroni Pharmaceuticals Nucleic Acid Drug CRO Services
Beroni Group’s AI-based Drug R&D Model Achieves Technological Breakthrough
Beroni Group Has Made Significant Progress in the Field of iNKT Cell Anti-tumor Therapy
Beroni Group Has Successfully Developed a New Method for Improving Safety of Neural Stem Cells Used in the Treatment of Neurodegenerative Diseases
Beroni Group’s Ten-year Research Journey, Innovation Leads the Future

Beroni Group is an international biotechnological company listed on the National Stock Exchange (Australia) and traded on the OTC markets in the USA with business presence in Australia, China, Japan and the USA. It currently has four core businesses – research and development of new drugs and clinical trial, immune cell therapy including gene detection and diagnosis, immunotherapy for cancer treatment, diagnosis of infectious diseases and e-commerce based on the Internet sales of pharmaceutical, healthcare and cosmetic products.

About

About Beroni
Our History
Board of Directors
Management Team
Vision, Mission, and Values

Core Businesses

Cell Therapy
Anti-Cancer Drugs
Infectious Diseases
E-Commerce

Products

By Beroni China
By Beroni Japan
By Beroni USA

Copyrights© Beroni Group 2019 | All rights reserved |

website by chase e-Design